Oppenheimer initiated coverage on Olema Pharmaceuticals with a new price target

7/21/23 7:55:18 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Oppenheimer initiated coverage of Olema Pharmaceuticals with a rating of Outperform and set a new price target of $21.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$OLMA

Date	Price Target	Rating	Analyst
4/2/2024	$24.00	Buy	Goldman
1/30/2024	$20.00	Buy	Citigroup
7/21/2023	$21.00	Outperform	Oppenheimer
5/5/2023	$16.00	Overweight	CapitalOne
2/22/2023	$12.00	Outperform	Credit Suisse
7/6/2022	$16.00	Buy	Canaccord Genuity
6/9/2022	$12.00	Neutral → Buy	H.C. Wainwright
2/28/2022		Neutral	HC Wainwright & Co.